Should we vaccinate the better seroconverters or the most vulnerable? Game changing insights for COVID-19 vaccine prioritization policies

• Main Authors: Antoine AbdelMassih (Author), Meryam El Shershaby (Author), Hanya Gaber (Author), Menna Habib (Author), Nada Gamal (Author), Reem Husseiny (Author), Nada AlShehry (Author), Abeer Amin (Author), Bassant Heikal (Author), Nadine El-Husseiny (Author), Mai Moursi (Author), Habiba-Allah Ismail (Author), Sara Senoussy (Author), Reem ElSharkawy (Author), Hebat Allah AlZayat (Author), Ghada ElMahdy (Author), Hossameldin Moawad (Author), Ali Genena (Author), Ahmed ElKiki (Author), Mary Reda (Author), Mohamed Khalil (Author), Reem Al Ramady (Author), Noran Radwan (Author), Mariam Khaled- (Author), Hager Amin (Author), Rafeef Hozaien (Author), Aya Kamel (Author), Raghda Fouda (Author)
• Format: Book
• Published: SpringerOpen, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background With the rapid rise in COVID 19 cases incomparable to the number of vaccinations available, there has been a demand to prioritize the older age groups receiving the vaccine as they have more risk of morbidity and mortality and thus better outcome from vaccination. Main body Some...